It’s rare that my MSM patients know which STDs they ought to be screened for, and how often. Men who have sex with men don’t get screened often enough for diseases like syphilis, gonorrhea, and HIV.
A public relations debacle for a new class of syphilis tests is unwarranted, and really just a case of bad spin.
Despite some progress in reducing the incidence of gonorrhea in the United States, spyhillis and chlamydia continue to rise; women and girls make up an ever-increasing share of all those infected with HIV worldwide, and despite promises re: jobs! jobs! jobs! the Tea Party and conservative Republicans are gearing up to pat down your uterus daily.
New data suggest mixed progress and ongoing challenges in the United States when it comes to the three most commonly reported STDs: Chlamydia, Gonorrhea, and Syphilis.
We need to educate the American public that this “silent epidemic” – as STDs are frequently called – is real, in our midst, and we need to prioritize them as part of the national focus on prevention.
Chlamydia is still the number 1 STD in America. What are you going to do about it?
On April 16th, the CDC released new data about the rates of congenital syphilis (CS) and the trends are going totally in the wrong direction. Nearly 500 children were born in 2008 with a totally preventable life-threatening illness.
We are losing the battle on sexually transmitted infections in the United States, a loss that will have grave implications for public health. And in the first few months of my new job as executive director of the National Coalition of STD Directors, I’ve learned some things that will help us be more effective in this battle, if we take heed.
Syphillis is easily diagnosed and treated. Yet efforts to eliminate syphillis in specific geographic areas have failed because they ignored deep economic, social, and racial disparities that perpetuate the risks of infection and disease.
American Indian and Alaska Native communities represent smaller numbers but higher risks for STD infection than those found in other sub-groups in the U.S. population. Addressing these requires focused strategies.